Late Phase Human Trials
Biomarkers for Clinical Research
RBM can help optimize your Phase II and III studies by providing innovative sample collection capabilities and cost-effective, clinically-validated biomarker testing services.
- CustomMAPs: Accurately and reliably measure multiple biomarkers in your Phase II, III or IV clinical trial samples using our CustomMAP services. This is a cost-effective alternative to traditional immunoassay services.
- TruCulture™ is ideal for delivering consistent immunomonitoring data from clinical trial sites without specialized facilities or trained personnel.
- Therapeutically-focused MAPs: Apply disease-specific MAPs such as cardiovascular, inflammation, metabolic, kidney and oncology (coming in late 2010) to your late stage clinical trial samples. The resulting data will give you an unprecedented level of understanding that could help to identify unanticipated consequences, good or bad, resulting from the use of your compound.